Trinity Biotech | TRIB - Operating Expenses


Trinity Biotech reported $12.63M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
Bayer EUR 9.92B 121M Sep/2026
Bio-Rad Laboratories USD 7.6B 429.1M Sep/2026
EDAP TMS EUR 25.18M 6.37M Mar/2026
J&J USD 18.93B 1.09B Sep/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
OraSure Technologies USD 40.35M 2.45M Dec/2025
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Siemens EUR 17.6B 531M Jun/2026
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Tosoh JPY 287.29B 44.3B Sep/2026
Trinity Biotech USD 12.63M 255K Mar/2026
Veracyte USD 133.73M 7.37M Sep/2026